Page 79 - Bioterrorism

78

Can there be other reasons that we are being frightened about a flu pandemic? The Bush
administration bought $1.4 billion of Tamiflu® "to combat the bird flu". The Obama
administration wants to buy enough to treat 25% of the American population. Other governments
are stockpiling it as well. This is despite the fact that Tamiflu® doesn't work for the bird flu and is
not likely to work for the swine flu either. "After following WHO protocols in treating 41 victims
of the H5N1 bird flu virus (19% of the worldwide cases of bird flu reported to date), Nguyen
Tuong Van, MD, who runs the intensive care unit of the Center for Tropical Diseases in Hanoi,
Vietnam concluded that Tamiflu®, the drug most widely stockpiled around the world to combat a
potential bird flu pandemic, is "useless". (Wikipedia) Thus, the American taxpayers paid billions
of dollars for a drug to treat about 100 cases per year of the bird flu. Someone made a lot of
money from a drug that does not work for an epidemic that never happened. They are making
even more money this year. If only we were using that money for something useful like treating
malaria!“ writes Tennant.

Scientists are opposing a plan in Japan to mass vaccinate against the “swine flu” on the grounds
that the virus will re-assort itself into a hybrid H1N1/H5N1 strain or mutate into a new, more
lethal H5N1 strain. The nightmare scenario is that the mutated virus may take on the
characteristics of H5N1 or the avian flu

http://www.rense.com/general85/a1.htm

„The AH1N1 virus has infected some 100 students in Kobe, Japan. Many of the students have no
history of traveling abroad. There are plans underway to begin a mass vaccination against
AH1N1. However, there are misgivings in the international research community about
administering an AH1N1 vaccine.

The fear is that once a vaccination against AH1N1 is started, the virus will re-assort itself into a
hybrid H1N1/H5N1 strain or mutate into a new H5N1 strain. The current AH1N1 strain, as
previously reported by WMR, contains synthetically gene-spliced strains of two forms of human
flu viruses, two forms of swine flu viruses, and a single form of avian flu virus.

What researchers have told us is that as long as the current AH1N1 can infect humans, it will not
try to mutate. Even though there have been deaths from AH1N1, most of those infected are sick
for up to four days, take Tamiflu or similar drugs, and recover with immunity from the hybrid or
"novel" virus. The vaccination program will be a profit maker for such Big Pharma firms as
Sanofi-Aventis, GlaxoSmithKline and Baxter International.

However, with vaccinations, the AH1N1 virus will, of course, be rejected by human hosts and
cases around the world will decrease. However, then, the virus will begin to mutate in order to
successfully infect human hosts. And when that happens, the new, newly-mutated virus will
become much more transmissible and more pathogenic.

The nightmare scenario is that the new, mutated virus may take on the characteristics of H5N1 or
the avian flu. The vaccines administered for AH1N1 will be ineffective against the new strain of
H5N1 and the world may face a more deadly pandemic then the current AH1N1 outbreak. There
are scientists at WHO who are aware of this scenario but their alarm has been suppressed by
political and economic considerations. „

A lack of quality control of the vaccinations is as much a problem today as it was in 1918.

In the US, the differing standards applied by different groups are due to the fact that experiments
on engineered viruses such as the 1918 flu are approved on a case-by-case basis by Institutional